Secondary analysis of 2,871 SCOT trial participants having adjuvant chemotherapy for colorectal cancer: mean weight rose 1.2 kg in males and 0.8 kg in females; younger age, male sex and higher HRQoL were associated with greater gain; 19.5% gained and 7.3% lost >5%.
Secondary analysisn = 2,871
Varghese et al. Association of patient factors and health-related quality of life with weight changes during chemotherapy for colorectal cancer: secondary analysis of the SCOT trial